Epidemiology, EBV/HPV associations and pathology in nasopharyngeal carcinoma

Apuntes

SPECIAL ARTICLE Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up y P. Bossi 1z , A. T. Chan 2z , L. Licitra 3 , A. Trama 4 , E. Orlandi 5 , E. P. Hui 2 , J. Halámková 6 , S. Mattheis 7 , B. Baujat 8 , J. Hardillo 9 , L. Smeele 10 , C. van Herpen 11 , A. Castro 12 & J.-P. Machiels 13,14 , on behalf of the ESMO Guidelines Committee * and EURACAN 1 Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia, ASST-Spedali Civili, Brescia, Italy; 2 State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Shatin, Hong Kong, Special Administrative Region, People’s Republic of China; 3 Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori and University of Milan, Milan; 4 Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan; 5 Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy; 6 Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, C...